EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic analysis of community-associated multidrug-resistant Klebsiella quasipneumoniae subsp. similipneumoniae and the identification of the ST2059-KL1 clone in the U.S.

Jianping Jiang, Austin J Terlecky iD, Elena Shashkina, Meghan W Starolis iD, Liang Chen iD, Barry N Kreiswirth iD

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.01107-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Jianping Jiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA. Hauptthemen laut MEDLINE: Drug Resistance, Multiple, Bacterial, Klebsiella, Community-Acquired Infections, Klebsiella Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Klebsiella quasipneumoniae subsp. similipneumoniae is an important member of the K. pneumoniae species complex (KpSC) and is increasingly reported as multidrug-resistant (MDR) in healthcare- and community-associated infections. Since clinical laboratories do not routinely distinguish K. quasipneumoniae subsp. similipneumoniae from K. pneumoniae , national prevalence estimates, particularly for MDR, are lacking. In this study, a total of 2,006 community-associated MDR KpSC isolates were collected from 42 U.S. states, with 30 K. quasipneumoniae subsp. similipneumoniae isolates originating from 12 states identified using whole genome sequencing. All isolates were resistant to ceftriaxone and exhibited high rates of resistance to other antimicrobial agents, including ampicillin-sulbactam (56.7%, 17/30), levofloxacin (75.9%, 22/29), and trimethoprim-sulfamethoxazole (53.3%, 16/30). Notably, five isolates were also carbapenem-resistant. Genomic analysis resolved 10 sequence types (STs), with ST2059 ( n = 13) and ST414 ( n = 9) predominating. Ceftriaxone resistance in most isolates (90%, 27/30) was conferred by an extended-spectrum β-lactamase gene, predominantly bla CTX-M-15 (73.3%, 22/30); the remaining isolates carried either a carbapenemase ( bla KPC-3 ) or an AmpC β-lactamase ( bla CMY-2 ). Nanopore sequencing identified bla CTX-M-15 harbored on two types of IncFIB(Kpn3) antimicrobial resistance (AMR) plasmids, either with or without the conjugative tra gene cluster. Interestingly, the KL1 locus, associated with canonical hypervirulent K. pneumoniae strains, was detected in all ST2059 isolates. Further analysis of public genomic data showed that the KL1 locus is widely distributed across KpSC. KL1 phylogenetic analyses indicated frequent intrasubspecies recombination but limited intersubspecies exchange of KL1. The identification of the dominant MDR K. quasipneumoniae subsp. similipneumoniae KL1-ST2059 clone in the U.S. underscores the importance of ongoing genomic surveillance. IMPORTANCE Klebsiella quasipneumoniae subsp. similipneumoniae is an underrecognized member of the Klebsiella pneumoniae species complex that is frequently misidentified in clinical laboratories, leading to an incomplete understanding of its role in antimicrobial resistance. In this study, we used large-scale genomic surveillance of community-associated multidrug-resistant isolates across the U.S. to identify this subspecies as a reservoir of clinically relevant resistance plasmids. Notably, we detected a widely distributed ST2059 lineage carrying the K1 capsular locus, a feature traditionally associated with hypervirulent K. pneumoniae . These findings highlight the convergence of resistance and virulence-associated traits in an overlooked species and underscore the need for genomic surveillance to monitor emerging high-risk lineages in community settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, Multiple, BacterialKlebsiellaCommunity-Acquired InfectionsKlebsiella InfectionsAnti-Bacterial AgentsUnited StatesHumansMicrobial Sensitivity TestsBacterial ProteinsGenome, BacterialWhole Genome Sequencingbeta-LactamasesGenomics

Stichwörter der Autor:innen

KL1Klebsiella quasipneumoniae subsp. similipneumoniaeST2059multidrug-resistant

Substanzen

Anti-Bacterial AgentsBacterial Proteinsbeta-Lactamases

Autor:innen und Institutionen

  • Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
  • Quest Diagnostics, Secaucus, New Jersey, USA.
  • School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA.

ORCID-Profile: Austin J Terlecky, Meghan W Starolis, Liang Chen, Barry N Kreiswirth

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Jiang, J., Terlecky, A. J., Shashkina, E., Starolis, M. W., Chen, L., & Kreiswirth, B. N. (2026). Genomic analysis of community-associated multidrug-resistant Klebsiella quasipneumoniae subsp. similipneumoniae and the identification of the ST2059-KL1 clone in the U.S. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01107-26

Vancouver

Jiang J, Terlecky AJ, Shashkina E, Starolis MW, Chen L, Kreiswirth BN. Genomic analysis of community-associated multidrug-resistant Klebsiella quasipneumoniae subsp. similipneumoniae and the identification of the ST2059-KL1 clone in the U.S. Microbiology Spectrum. 2026. doi:10.1128/spectrum.01107-26

BibTeX
@article{Jiang2026,
  author = {Jiang, Jianping and Terlecky, Austin J and Shashkina, Elena and Starolis, Meghan W and Chen, Liang and Kreiswirth, Barry N},
  title = {Genomic analysis of community-associated multidrug-resistant Klebsiella quasipneumoniae subsp. similipneumoniae and the identification of the ST2059-KL1 clone in the U.S},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.01107-26}
}
Kostenlos starten →